Adma Biologics Inc (NASDAQ: ADMA) on Monday, soared 3.74% from the previous trading day, before settling in for the closing price of $18.44. Within the past 52 weeks, ADMA’s price has moved between $4.39 and $23.64.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 73.38%. The company achieved an average annual earnings per share of 494.23%. With a float of $228.48 million, this company’s outstanding shares have now reached $236.38 million.
The extent of productivity of a business whose workforce counts for 624 workers is very important to gauge. In terms of profitability, gross margin is 48.79%, operating margin of 30.01%, and the pretax margin is 19.16%.
Adma Biologics Inc (ADMA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Adma Biologics Inc is 3.35%, while institutional ownership is 88.44%. The most recent insider transaction that took place on Nov 22 ’24, was worth 317,250. In this transaction CFO and Treasurer of this company sold 15,000 shares at a rate of $21.15, taking the stock ownership to the 199,433 shares. Before that another transaction happened on Nov 22 ’24, when Company’s President and CEO sold 48,967 for $21.10, making the entire transaction worth $1,033,204. This insider now owns 1,989,007 shares in total.
Adma Biologics Inc (ADMA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 494.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.00% during the next five years compared to 38.68% growth over the previous five years of trading.
Adma Biologics Inc (NASDAQ: ADMA) Trading Performance Indicators
Adma Biologics Inc (ADMA) is currently performing well based on its current performance indicators. A quick ratio of 3.26 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.81. Likewise, its price to free cash flow for the trailing twelve months is 56.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.28, a number that is poised to hit 0.15 in the next quarter and is forecasted to reach 0.73 in one year’s time.
Technical Analysis of Adma Biologics Inc (ADMA)
The latest stats from [Adma Biologics Inc, ADMA] show that its last 5-days average volume of 2.06 million was inferior to 2.28 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 91.19%. Additionally, its Average True Range was 0.82.
During the past 100 days, Adma Biologics Inc’s (ADMA) raw stochastic average was set at 45.73%, which indicates a significant decrease from 97.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.20% in the past 14 days, which was lower than the 65.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.14, while its 200-day Moving Average is $14.11. Now, the first resistance to watch is $19.38. This is followed by the second major resistance level at $19.64. The third major resistance level sits at $20.08. If the price goes on to break the first support level at $18.69, it is likely to go to the next support level at $18.25. Assuming the price breaks the second support level, the third support level stands at $17.99.
Adma Biologics Inc (NASDAQ: ADMA) Key Stats
Market capitalization of the company is 4.52 billion based on 236,390K outstanding shares. Right now, sales total 258,220 K and income totals -28,240 K. The company made 119,840 K in profit during its latest quarter, and 35,910 K in sales during its previous quarter.
